Drugs / HBc-HBs/AS01B-4
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03866187 | Mar 2019 → Oct 2024 | chronic hepatitis B virus infection | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HBc-HBs/AS01B-4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03866187 ↗ |
| Route | Intramuscular | “by intramuscular injection in the deltoid of the non-dominant arm” NCT03866187 ↗ |